Efficacy and Safety Study of Nidadd in the Management of Hyperlipidemia

• Status: Completed
• Trial end date: 2005-08-01

Summary

To assess the efficacy and safety of Nidadd (extended-release niacin) in patients with hyperlipidemia.

• Phase: Phase 3

Details

• Lead Sponsor: Genovate Biotechnology Co., Ltd.,